The Lancet. Infectious Diseases
Overview
The Lancet Infectious Diseases is a renowned peer-reviewed medical journal that focuses on the latest research and developments in the field of infectious diseases. It covers a wide range of topics including epidemiology, pathogenesis, diagnosis, treatment, and prevention of infectious diseases. With its rigorous editorial process and high-quality content, the journal serves as a valuable resource for healthcare professionals, researchers, and policymakers in the fight against infectious diseases worldwide.
Details
Details
Abbr.
Lancet Infect Dis
Start
2001
End
Continuing
Frequency
Monthly
p-ISSN
1473-3099
e-ISSN
1474-4457
Country
United States
Language
English
Specialty
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 229
291
SJR / Ranks: 169
6329
CiteScore / Ranks: 42
55.60
JIF / Ranks: 24
56.3
Recent Articles
1.
2.
3.
Krasemann S, Fodjo J, Mohamed O, Barhishindi I, Tshongo C, Bisimwa A, et al.
Lancet Infect Dis
. 2025 Mar;
PMID: 40086463
No abstract available.
4.
Berti G, Manaresi E, Vischini G, Provenzano M, Corradetti V, Giannella M, et al.
Lancet Infect Dis
. 2025 Mar;
PMID: 40081401
We report the case of a 34-year-old male recipient of an ABO-incompatible living donor kidney transplant who was repeatedly hospitalised for anaemia. Acute kidney injury in a patient with severe...
5.
Uren H, Aliieva N, Matolinets N, Hemsley C, Holcomb J, Samchuk O, et al.
Lancet Infect Dis
. 2025 Mar;
PMID: 40064191
No abstract available.
6.
7.
8.
Borges A, Russell M, Tait D, Scriba T, Nemes E, Skallerup P, et al.
Lancet Infect Dis
. 2025 Mar;
PMID: 40056922
Background: People with tuberculosis who complete treatment remain at risk of recurrent disease. The vaccine H56:IC31 has been shown to be safe and immunogenic in phase 1 and 2 studies,...
9.
Rosa W, Pandey S, Wisniewski R, Blinderman C, Cheong M, Correa-Morales J, et al.
Lancet Infect Dis
. 2025 Mar;
PMID: 40049189
Global rates of antimicrobial consumption increased by 65% between 2000 and 2015, by 16% between 2016 and 2023, and are estimated to increase by an additional 52% by 2030. Antimicrobial...
10.